References
- Gibson GB, Mc Donald CM, Marks GB. Asthma in older patients. Lancet 2010; 376:803–813.
- Chotirmall SH, Watts M, Branagan P, Donegon CF, Moore A, Mc Elvaney NG. Diagnosis and management of asthma in older patients. J Am Geriatr Soc 2009; 57:901–909.
- Banerjee DK, Lee GS, Mailk SK, Dalz S. Underdiagnosis of asthma in elderly. Br J Dis Chest 2008; 81:23–29.
- GINA Report. Global strategy for asthma management and prevention. 2008. Available at: http://www.gina.org/. Accessed May 20, 2008.
- Bozek A, Jarzab J. Improved activity and mental function related to proper antiasthmatic treatment in elderly patients with Alzheimer’s disease. Allergy Asthma Proc 2011; 32(5):341–345.
- Garcia MLG, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 2005; 116(2):360–369.
- Israel E, Chervinsky PS, Friedman B, Van Bavel J, Skalky CS, Ghannam AF, Bird SR, Edelman JM. Effects of montelukast and beclomethasone on airway function and asthma control. J Allergy Clin Immunol 2002; 110:847–854.
- Joos S, Miksch A, Szecsenyi J, Wiesler B, Grouven U, Kaiser T, Schneider A. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008; 63(5):453–462.
- Virchow JC, Mehta A, Ljungbald L, Mitefessel H. A subgroup analysis of the MONICA study: a 12-month, open label study of add-on montelukast treatment in asthma patients. J Asthma 2010; 47:968–993.
- Lee JH, Haselkron T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma. Insight from the TENOR study. Chest 2007; 132:1882–1889.
- Bae YJ, Kim TB, Jee HW, Chang YS, Cho YS, Moon HB. Severe asthma patients in Korea overestimate their adherence to inhaled corticosteroids. J Asthma 2009; 46:591–595.
- Bozek A, Jarzab J. Adherence to asthma therapy in elderly patients. J Asthma 2010; 47:162–166.
- Bousquet J, Demoly P, Humbert M. Montelukast in guidelines and beyond. Adv Ther 2009; 26:575–587.
- Tohda Y, Fujimura M, Taniguchi H, Takagi K, Igarashi T, Yasuhara H, Takahashi K, Nakajima S. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exp Allergy 2002; 32:1180–1186.
- Snyder L, Blanc PD, Katz PP, Yelin EH, Eisner MD. Leukotriene modifier use and asthma severity: how is a new medication being used by adults with asthma? Arch Intern Med 2004; 164:617–622.